Company intelligence / Profile preview

PRECISE

Winston-Salem, North Carolina, United States

Ownership: Private
Employees: ~45
Development stage: Other

Overview

Precise Bio is a regenerative medicine company that develops a proprietary 4D bio-fabrication platform to engineer functional human tissues and organs. The company's technology integrates cell expansion, biomaterials, and high-resolution 3D bioprinting to produce scalable and repeatable biological implants. Its lead programs include a bio-fabricated human cornea for ophthalmology and a 3D cardiac tissue patch for treating patients post-myocardial infarction. By utilizing a patient's own cells, Precise Bio aims to address the global shortage of donor tissues and provide personalized, life-saving therapeutic solutions.

Therapeutic areas: CardiovascularOphthalmology
Modalities: Cell therapy3D bioprintingTissue engineering4D bio-fabrication
Industry: Implantable Medical Devices

Partnerships

Carl Zeiss Meditec

Beyond the preview

Go deeper on PRECISE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRECISE.

Explore the full profile